on Ottobock SE & Co. KGaA
Ottobock Announces IPO Plans for 2025
Ottobock SE & Co. KGaA, a leader in the MedTech industry specializing in human bionics, has unveiled its intention to go public in 2025. The company aims to list on the Frankfurt Stock Exchange's Prime Standard, hoping to raise EUR 100 million through a mix of existing and new shares.
With a century-long history in innovation, Ottobock has pioneered advancements in prosthetics and neuro-orthotics. Its robust R&D infrastructure, featuring AI and digital manufacturing, supports its commitment to pushing technological boundaries.
The IPO aims to enhance financial flexibility, enabling Ottobock to continue investing in future tech. With strong revenue growth and a 22.4% EBITDA margin, the company is positioned for expansion in the growing global bionics market.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Ottobock SE & Co. KGaA news